According to a report by Pledge Times on August 6, Professor Tony Lawler, director of the Therapeutic Goods Administration (TGA) in Australia, emphasized during a meeting that the Therapeutic Goods Order 100 will ensure the quality and safety of therapeutic e-cigarette products. He acknowledged the challenges pharmacists face when evaluating unregistered products, and highlighted that regulatory reforms and enhanced border control measures help manage imported products. These products must be regulated as therapeutic goods, which is why they are not sold in retail environments.
He assured pharmaceutical professionals that the responsibility for ensuring the safety of e-cigarette products to the public does not solely rest on community pharmacists.
He also emphasized strict control over the concentration, flavor, and color of e-cigarettes, and pointed out that e-cigarettes are being withdrawn from retail environments to ensure they are managed by health professionals. He stressed that only e-cigarette products that meet TGA standards can be imported and sold in Australia.
According to reports, the Therapeutic Goods Administration (TGA) and the Queensland Department of Health recently conducted a two-day joint enforcement operation, seizing over 10,000 nicotine pouches and hundreds of illegal e-cigarette products. The confiscated e-cigarettes are suspected of violating the new commercial possession laws under the Therapeutic Goods and Other Legislation Amendment (E-cigarette Reform) Act, which came into effect on July 1st. These laws prohibit Australian retailers from providing any e-cigarette products, even with a prescription, and prohibit the possession of e-cigarettes in retail premises.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
